CCL Products (India) Limited's Nomination and Remuneration Committee, at its meeting held on 07th May 2026, approved the grant of 1,61,850 stock options and the vesting of 1,48,473 options under the CCL Employee Stock Option Scheme-2022. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In the same meeting, the committee also approved structural and organisational changes to the company's Senior Management Personnel.

ESOP Grant and Vesting Details

The CCL Employee Stock Option Scheme-2022 is compliant with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The newly granted options carry an exercise price of Rs.2/- per share at face value, and eligible employees may exercise their options within 2 years from the respective date of vesting. Vesting is contingent upon employees achieving earmarked targets for the respective years, as determined by the Nomination and Remuneration Committee.

The following table summarises the key details of the ESOP activity disclosed under Annexure-1:

It was also noted that 6,475 options have lapsed or been forfeited following the resignation of eligible employees. Options exercised, money realised by exercise, and total shares arising from exercise were reported as not applicable at this stage.

Revised Senior Management Personnel

In addition to the ESOP-related decisions, the Nomination and Remuneration Committee took note of structural and organisational changes within the company. The committee approved the redefinition and reclassification of Senior Management Personnel in accordance with Regulation 16(1)(d) read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, aligned with the current organisational structure and reporting hierarchy.

The revised list of Senior Management Personnel is as follows:

The intimation was signed by Sridevi Dasari, Company Secretary & Compliance Officer, on behalf of CCL Products (India) Limited, and submitted to both the National Stock Exchange of India Limited and BSE Limited as required under the applicable SEBI regulations.

The promoters and promoter group of CCL Products (India) Limited have submitted a formal declaration to the National Stock Exchange of India Limited and BSE Limited, confirming that no encumbrance of shares was created, directly or indirectly, during the financial year ended 31.03.2026. The disclosure was filed on 03.04.2026 by Company Secretary and Compliance Officer Sridevi Dasari, pursuant to Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Disclosure Under SEBI Takeover Regulations

The declaration was made by the promoters, including Persons Acting in Concert (PAC), affirming compliance with the applicable SEBI regulations governing substantial acquisition of shares and takeovers. The filing confirms that the promoter group collectively refrained from creating any form of encumbrance on their shareholding throughout the financial year ended 31.03.2026. The disclosure was signed by Challa Srishant on behalf of the promoters.

Promoter and Promoter Group Shareholding as on 31.03.2026

The filing includes a detailed list of promoters and promoter group members along with their respective shareholding positions as on 31.03.2026. The table below presents the shareholding details as annexed to the declaration:

Filing Details

The disclosure was addressed to both the Listing Department of the National Stock Exchange of India Limited and the Corporate Relations Department of BSE Limited. The filing was submitted by CCL Products (India) Limited, headquartered at 8-2-269/4 A, Road No. 2, Banjara Hills, Hyderabad – 500034, Telangana, with its registered office located at Duggirala, Guntur Dist. 522330, Andhra Pradesh, India.